Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 14
2010 574
2011 6475
2012 6955
2013 8014
2014 8280
2015 8376
2016 8307
2017 8269
2018 8089
2019 8439
2020 9359
2021 9539
2022 8055
2023 2534

Text availability

Article attribute

Article type

Publication date

Search Results

91,402 results

Results by year

Filters applied: . Clear all
Page 1
HIV entry: a game of hide-and-fuse?
Melikyan GB. Melikyan GB. Curr Opin Virol. 2014 Feb;4:1-7. doi: 10.1016/j.coviro.2013.09.004. Epub 2013 Nov 1. Curr Opin Virol. 2014. PMID: 24525288 Free PMC article. Review.
HIV has long been thought to fuse directly with the cell plasma membrane. However, several lines of evidence suggest that endocytic entry of HIV can lead to infection and, moreover, that endocytosis could be the predominant HIV entry pathway into different ce …
HIV has long been thought to fuse directly with the cell plasma membrane. However, several lines of evidence suggest that endocytic e …
Advancing an HIV vaccine; advancing vaccinology.
Burton DR. Burton DR. Nat Rev Immunol. 2019 Feb;19(2):77-78. doi: 10.1038/s41577-018-0103-6. Nat Rev Immunol. 2019. PMID: 30560910 Free PMC article. Review.
Of any pathogen, HIV provides perhaps the greatest challenge to successful vaccine development. ...
Of any pathogen, HIV provides perhaps the greatest challenge to successful vaccine development. ...
Defining HIV-1 transmission clusters based on sequence data.
Hassan AS, Pybus OG, Sanders EJ, Albert J, Esbjörnsson J. Hassan AS, et al. AIDS. 2017 Jun 1;31(9):1211-1222. doi: 10.1097/QAD.0000000000001470. AIDS. 2017. PMID: 28353537 Free PMC article. Review.
: Understanding HIV-1 transmission dynamics is relevant to both screening and intervention strategies of HIV-1 infection. ...We start by introducing the concepts and methodologies of how HIV-1 transmission clusters usually have been defined. We then present t …
: Understanding HIV-1 transmission dynamics is relevant to both screening and intervention strategies of HIV-1 infection. ...W …
Future technologies for monitoring HIV drug resistance and cure.
Parikh UM, McCormick K, van Zyl G, Mellors JW. Parikh UM, et al. Curr Opin HIV AIDS. 2017 Mar;12(2):182-189. doi: 10.1097/COH.0000000000000344. Curr Opin HIV AIDS. 2017. PMID: 28059958 Free PMC article. Review.
PURPOSE OF REVIEW: Sensitive, scalable and affordable assays are critically needed for monitoring the success of interventions for preventing, treating and attempting to cure HIV infection. This review evaluates current and emerging technologies that are applicable for bot …
PURPOSE OF REVIEW: Sensitive, scalable and affordable assays are critically needed for monitoring the success of interventions for preventin …
Drug resistance mutations in HIV: new bioinformatics approaches and challenges.
Blassel L, Zhukova A, Villabona-Arenas CJ, Atkins KE, Hué S, Gascuel O. Blassel L, et al. Curr Opin Virol. 2021 Dec;51:56-64. doi: 10.1016/j.coviro.2021.09.009. Epub 2021 Sep 28. Curr Opin Virol. 2021. PMID: 34597873 Free article. Review.
Drug resistance mutations appear in HIV under treatment pressure. Resistant variants can be transmitted to treatment-naive individuals, which can lead to rapid virological failure and can limit treatment options. ...We review recent bioinformatics developments and in parti …
Drug resistance mutations appear in HIV under treatment pressure. Resistant variants can be transmitted to treatment-naive individual …
Ethical issues in HIV phylogenetics and molecular epidemiology.
Mehta SR, Schairer C, Little S. Mehta SR, et al. Curr Opin HIV AIDS. 2019 May;14(3):221-226. doi: 10.1097/COH.0000000000000538. Curr Opin HIV AIDS. 2019. PMID: 30946143 Free PMC article. Review.
PURPOSE OF REVIEW: HIV phylogenetic and molecular epidemiology analyses are increasingly being performed with a goal of improving HIV prevention efforts. ...RECENT FINDINGS: Several working groups have recently outlined the major issues surrounding the use of molecu …
PURPOSE OF REVIEW: HIV phylogenetic and molecular epidemiology analyses are increasingly being performed with a goal of improving …
HIV transmission and source-sink dynamics in sub-Saharan Africa.
Okano JT, Sharp K, Valdano E, Palk L, Blower S. Okano JT, et al. Lancet HIV. 2020 Mar;7(3):e209-e214. doi: 10.1016/S2352-3018(19)30407-2. Epub 2020 Feb 14. Lancet HIV. 2020. PMID: 32066532 Free PMC article. Review.
Multiple phylogenetic studies of HIV in sub-Saharan Africa have shown that mobility-driven transmission frequently occurs: many communities export and import strains. ...Additionally, we discuss the need for a new generation of HIV transmission models that are more …
Multiple phylogenetic studies of HIV in sub-Saharan Africa have shown that mobility-driven transmission frequently occurs: many commu …
Review: HIV-1 phylogeny during suppressive antiretroviral therapy.
Bale MJ, Kearney MF. Bale MJ, et al. Curr Opin HIV AIDS. 2019 May;14(3):188-193. doi: 10.1097/COH.0000000000000535. Curr Opin HIV AIDS. 2019. PMID: 30882485 Free PMC article. Review.
This article reviews methods for interrogating intrahost HIV-1 diversity, addresses the ongoing debate regarding HIV-1 compartmentalization and replication during ART, and summarizes recent findings on the effects of curative strategies on HIV-1 populations. …
This article reviews methods for interrogating intrahost HIV-1 diversity, addresses the ongoing debate regarding HIV-1 compart …
Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution.
Alexander TS. Alexander TS. Clin Vaccine Immunol. 2016 Apr 4;23(4):249-53. doi: 10.1128/CVI.00053-16. Print 2016 Apr. Clin Vaccine Immunol. 2016. PMID: 26936099 Free PMC article. Review.
Fourth- and fifth-generation HIV assays added p24 antigen detection to the screening assay, reducing the test-negative window to 11 to 14 days. ...HIV infection may now be detected approximately 2 weeks postexposure, with a reduced number of false-positive results.. …
Fourth- and fifth-generation HIV assays added p24 antigen detection to the screening assay, reducing the test-negative window to 11 t …
91,402 results
You have reached the last available page of results. Please see the User Guide for more information.